Close Menu

Beckman Coulter

News Scan: Feb 13, 2009

Premium

Trevena, Ligand Pharmaceuticals, Ibidi, Seahorse Bioscience

Regardless of the outcome of the first phase of the trial, Life Technologies declared victory last week, saying that the patents are irrelevant for current or future versions of the SOLiD technology.

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.